Answers are grounded in this paper and cite their sources.
Calcium overload exhibits significant anti-tumor potential by inducing abnormal intracellular Ca 2+ accumulation, which disrupts mitochondrial and endoplasmic reticulum (ER) functions, thereby triggering apoptosis. However, its clinical application is currently hindered by challenges such as poor tumor-targeting capabilities, insufficient tumor accumulation, and incomplete mechanistic understanding. This review systematically analyzes the structural and functional coupling between the ER and mitochondria to elucidate the mechanisms of calcium overload-mediated cell death. We highlight how Ca 2+ acts as a critical trigger to amplify mitochondria-associated ER stress, fostering a self-amplifying loop of crosstalk that initiates tumor cell death pathways. Furthermore, we summarize recent advances in targeted Ca 2+ delivery using calcium-based nanocarriers combined with emerging modalities like sonodynamic therapy (SDT) and photothermal therapy (PTT), highlighting their synergistic antitumor potential. Compared with previous reviews, this work focuses on recent calcium-based nanosystems, sequential ER–mitochondria damage during Ca 2+ overload, the MAM-associated IP3R–GRP75–VDAC1–MCU axis, and future strategies for tumor-targeted, TME-responsive, and multimodal synergistic therapy. By summarizing current research, this review aims to provide a prospective outlook for novel anticancer therapies that disrupt intracellular Ca 2+ homeostasis. By summarizing current research, this review aims to provide a prospective outlook for the novel anti-cancer therapies that target the disruption of intracellular Ca 2+ homeostasis.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: